Straits Times Index
3,307.82 +7.82 (+0.24%) Nikkei
38,637.13 +4.11 (+0.01%) Hang Seng
17,990.14 -345.18 (-1.88%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,493.29 -786.36 (-1.20%) CMC Crypto 200
1,354.79 -27.87 (-2.02%)
TMCI Jun 2024 17.500 call
| Previous close | 1.7500 |
| Open | 1.5000 |
| Bid | 0.0500 |
| Ask | 1.5500 |
| Strike | 17.50 |
| Expiry date | 2024-06-21 |
| Day's range | 1.5000 - 1.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 40 |
GlobeNewswireTreace to Present at Truist Securities MedTech Conference
Tuesday, June 18, 2024 at 8:00 am Eastern TimePONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside
GuruFocus.comDirector Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
GuruFocus.comDirector Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI)
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
